Hemodynamic Support Devices

This hemodynamic support systems include intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or tandemheart, and ventricular assist devices (VAD).

HeartMate PHP, Thoratec, St. Jude medical

The HeartMate PHP (percutaneous heart pump) is the latest acute hemodynamic support technology released by Thoratec, which recently received CE mark in Europe. The PHP is currently in U.S.clinical trials.

Feature | Ventricular Assist Devices (VAD) | July 22, 2015

July 22, 2015 — St. Jude Medical and Thoratec announced that the boards of directors of both companies have...

Thoratec, HeartMate PHP. CE Mark approval, SHIELD I
Feature | Ventricular Assist Devices (VAD) | July 15, 2015

July 15, 2015 - Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval,...

Abiomed, U.S. headquarters expansion, Impella 2.5, RP, jobs
News | Ventricular Assist Devices (VAD) | July 09, 2015

July 9, 2015 - During an event with Massachusetts Gov. Charlie Baker in June, Abiomed announced a...

ECRI Institute, review, Impella RP, Abiomed
News | Ventricular Assist Devices (VAD) | June 11, 2015

June 11, 2015 - ECRI Institute recently reviewed published data on Abiomed's Impella RP (Right Percutaneous)...

UH Case Medical Center, Impella RP, first in Ohio, Abiomed, Mobile Learning Lab
News | Ventricular Assist Devices (VAD) | June 09, 2015

June 9, 2015 - University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute...

Beaumont Hospital Royal Oak, Impella RP, right-side heart failure, Abiomed
News | June 04, 2015

June 4, 2015 - Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally...

IABP, peer review, Maquet, Journal of Invasive Cardiology
Feature | June 01, 2015

June 1, 2015 — Maquet Getinge Group announced the publication of a manuscript describing the exploration of the...

Thoratec, HeartMate II, ROADMAP
News | May 04, 2015

May 4, 2015 — Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness...

Protek Duo, VV ECLS, CE mark, CardiacAssist, veno-venous cannula

Image courtesy of CardiacAssist Inc.

News | April 27, 2015

April 27, 2015 — CardiacAssist Inc. announced that it received a Class 3 CE-mark for its Protek Duo veno-venous...

intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective
News | April 09, 2015

April 9, 2015 — Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic...

expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

The Abiomed Impella device

Feature | April 07, 2015

April 7, 2015 — An expert consensus statement released by four leading cardiovascular societies provides new...

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study
News | April 02, 2015

April 2, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an...

Impella, FDA, high risk PCI, abiomed

Abiomed's Impella 2.5 now has an FDA indication for high-risk PCI.

Technology | March 25, 2015

March 24, 2015 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for...

News | January 30, 2015

January 30, 2015 — SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a...

Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

HeartMate III image courtesy of Thoratec

News | January 27, 2015

January 27, 2015 — NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of...

Overlay Init